Searched for
VERAPAMIL HYDROCHLORIDE
Zydus Lifesciences shares in focus after US FDA nods for diabetes and blood pressure drugsZydus Lifesciences is set to be in focus after it received tentative approval from the United States Food and Drug Administration for Empag...
Zydus Lifesciences shares in focus after USFDA nod for Verapamil Hydrochloride ER TabletsZydus Lifesciences will be in focus on Wednesday after receiving final USFDA approval for its Verapamil Hydrochloride Extended-Release Tabl...
Glenmark recalls 1,200 bottles of generic hypertension drug in USGlenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a m...
Zydus Cadila gets USFDA nod for generic drugsThe company has received final approval from the US Food and Drug Administration (USFDA) for the medication in 300 mg strength, Zydus Cadil...
Apotex Inc recalls hypertension drug made by Indian armApotex Inc has initiated a recall of 2,075 bottles of blood pressure treatment tablet 'Verapamil Hydrochloride' manufactured by Bangalore b...
Glenmark gets USFDA nod to sell generic blood pressure drug TarkaThe approval for trandolapril and verapamil hydrochloride extended release tablets has been granted to Glenmark Generics Inc.
Glenmark under pressure after losing patent battle to AbbottShares of Glenmark Pharmaceuticals saw profit booking after the company announced that it has lost appeal to invalidate Abbott's patent for...
- Glenmark confirms patent challenge of fluticasone lotion
Glenmark Generics Ltd's US subsidiary confirmed Nycomed US filed a patent infringement lawsuit on Dec 12, 2008, in the US District Court, E...
- Glenmark confirms Abbott suit against Tarka generic
Glenmark Pharmaceuticals has confirmed that Abbott has filed a suit in the US District Court of New Jersey on December 7, seeking to preven...
- Sanofi, Abbott file lawsuit against Glenmark
Sanofi-Aventis SA and Abbott Laboratories have jointly filed a lawsuit against Glenmark to prevent the Indian company from selling its hype...